Skip to main content
. 2021 Sep 23;72:103577. doi: 10.1016/j.ebiom.2021.103577

Figure 1.

Figure 1

Figure 1

(a) Schematic representation of a cancer biomarker which is prognostic but not predictive. Tx, cohort received treatment; M+, biomarker positive; no Tx, cohort is treatment naïve; M-, biomarker negative. (b) Flow diagram summary of a potential trial structure.